MEGHAN SHOWMAN: Open Payments
NPI 1275940116 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,696 in 162 payments from 19 companies in 2025. Trend: 2023 $2,419 · 2024 $4,702 · 2025 $3,696
Food & beverage: $3,676Education: $20
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 25 | $739 |
| Novartis Pharmaceuticals Corporation | 29 | $454 |
| Bayer Healthcare Pharmaceuticals Inc. | 11 | $322 |
| Actelion Pharmaceuticals US, Inc. | 12 | $321 |
| CVRx, Inc. | 10 | $285 |
| Kestra Medical Technology Services, Inc. | 4 | $230 |
| PFIZER INC. | 12 | $214 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $192 |
| E.R. Squibb & Sons, L.L.C. | 20 | $173 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 5 | $161 |
Products named: LEQVIO, Barostim Neo System, Kerendia, UPTRAVI, Assure WCD, FARXIGA, JARDIANCE, VYNDAQEL.
Industry payments across FL — which companies pay providers there.
